Seres Therapeutics Inc (MCRB)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

200 SIDNEY STREET CAMBRIDGE, MA 02139

Seres Therapeutics, Inc. operates as a microbiome therapeutics platform company. The Company focuses on developing biological drugs, which are designed to restore health by repairing the function of a dysbiotic microbiome. Seres Therapeutics also conducts research on metabolic diseases.

Data based on most recent fiscal year report
Market Cap239.434 Million Shares Outstanding70.01 Million Avg Volume475.374 Thousand
1-Yr BETA vs S&P TR1.741 Current Ratio2.2 Quick Ratio2.2
View SEC Filings from MCRB instead.

View recent insider trading info

Funds Holding MCRB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MCRB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KIM LORENCE H. CHIEF FINANCIAL OFFICER

  • Officer
1,360,510 2020-01-22 1

KENDER RICHARD N

  • Director
0 2020-01-02 1

DERE WILLARD H

  • Director
0 2020-01-02 1

HUTT PETER BARTON

  • Director
3,924 2019-11-20 0

CHAPMAN MARCUS SEE REMARKS

  • Officer
8,600 2019-11-01 2

BERENSON STEPHEN

  • Director
0 2019-08-05 2

AUSIELLO DENNIS A

  • Director
0 2019-07-01 1

POMERANTZ ROGER

  • Director
0 2019-06-28 1

AFEYAN NOUBAR

  • Director
  • 10% Owner
0 2019-06-27 2

ZAUSNER MERYL

  • Director
0 2019-06-25 1

FLAGSHIP PIONEERING INC.

FLAGSHIP PIONEERING FUND VI GENERAL PARTNER LLC

FLAGSHIP PIONEERING FUND VI, L.P.

NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

NUTRITIONAL HEALTH LTP FUND, L.P.

  • 10% Owner
4,444,444 2019-06-18 1

BEHAR GREGORY

  • Director
0 2019-06-13 1

GRAVES KURT

  • Director
0 2019-06-13 1

HENN MATTHEW R. CHIEF SCIENTIFIC OFFICER

  • Officer
4,500 2019-02-01 2

COOK DAVID N SEE REMARKS

  • Officer
147,435 2019-01-26 1

SHAFF ERIC D. SEE REMARKS

  • Officer
12,842 2019-01-25 1

AUNINS JOHN G. CHIEF TECHNOLOGY OFFICER

  • Officer
92,750 2019-01-25 1

DESROSIER THOMAS CHIEF LEGAL OFFICER AND EVP

  • Officer
16,054 2019-01-25 1

HORGAN KEVIN CHIEF MEDICAL OFFICER AND EVP

  • Officer
0 2019-01-25 1

TRUCKSIS MICHELE SEE REMARKS

  • Officer
4,893 2018-01-26 0

CAUTREELS WERNER PRESIDENT AND CEO

  • Officer
  • Director
321,203 2017-11-13 0

HASHAD WAEL EVP & CHIEF COMMERCIAL OFFICER

  • Officer
0 2017-01-26 0

NESTLE HEALTH SCIENCE US HOLDINGS, INC.

NESTLE SA

NIMCO US, INC.

  • 10% Owner
7,552,084 2016-11-23 0

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND 2007, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

AFEYAN NOUBAR

KANIA EDWIN M JR

  • 10% Owner
No longer subject to file 2016-09-22 0

AFEYAN NOUBAR

FLAGSHIP VENTURES FUND 2007, L.P.

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

FLAGSHIP VENTURELABS IV, LLC

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

KANIA EDWIN M JR

  • Director
  • 10% Owner
14,641,852 2016-05-25 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments